Integrated Wealth Concepts LLC Veru Inc. Transaction History

Integrated Wealth Concepts LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.49 - $0.7 $1,017 - $1,453	2,076 Added 2.27%	93,726 $54,000
Q1 2025 May 15, 2025	BUY	$0.45 - $1.28 $2,587 - $7,360	5,750 Added 6.69%	91,650 $44,000
Q4 2024 Feb 14, 2025	BUY	$0.58 - $0.93 $11,890 - $19,065	20,500 Added 31.35%	85,900 $55,000
Q3 2024 Nov 14, 2024	BUY	$0.77 - $1.04 $770 - $1,040	1,000 Added 1.55%	65,400 $50,000
Q2 2024 Aug 14, 2024	BUY	$0.76 - $1.79 $10,260 - $24,165	13,500 Added 26.52%	64,400 $54,000

Q1 2024 May 15, 2024	BUY	$0.37 - $0.72 $14,800 - $28,800	40,000 Added 366.97%	50,900 $35,000
Q2 2023 Aug 15, 2023	BUY	$0.98 - $1.49 $10,682 - $16,241	10,900 New	10,900 $12,000

10.6M

32.7K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $204M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Wealth Concepts LLC with notifications on news.